TY  - JOUR
T1  - When choosing statin therapy: The case for generics
AU  - Green JB, Ross JS, Jackevicius CA, Shah ND, Krumholz HM
Y1  - 2013/02/11
N1  - 10.1001/jamainternmed.2013.1529
JO  - JAMA Internal Medicine
SP  - 229
EP  - 232
VL  - 173
IS  - 3
N2  - The development of “Top 5” lists across specialties and at regular intervals can help to remind physicians that optimal care is often possible at a lower cost. For purposes of cardiovascular risk reduction, generic statins, or their brand equivalents if priced similarly, remain the appropriate choice for dyslipidemic patients initiating statin therapy. In this article, we review the evidence supporting the choice of generic statins.
SN  - 2168-6106
M3  - doi: 10.1001/jamainternmed.2013.1529
UR  - http://dx.doi.org/10.1001/jamainternmed.2013.1529
ER  -